| European Federation of Internal Medicine

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News

Type: News Feed

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 16:45

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 15, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Sirturo, bedaquiline, Date of authorisation: 05/03/2014, Revision: 23, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 16:35

Human medicines European public assessment report (EPAR): Sirturo, bedaquiline, Date of authorisation: 05/03/2014, Revision: 23, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Sirturo, bedaquiline, Date of authorisation: 05/03/2014, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 30, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 16:30

Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 30, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 16:20

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 16:15

Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): SonoVue, sulphur hexafluoride, Date of authorisation: 26/03/2001, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 16:08

Human medicines European public assessment report (EPAR): SonoVue, sulphur hexafluoride, Date of authorisation: 26/03/2001, Revision: 21, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): SonoVue, sulphur hexafluoride, Date of authorisation: 26/03/2001, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 10, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 16:00

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 10, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 60, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 15:50

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 60, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 60, Status: Authorised

Human medicines European public assessment report (EPAR): Nyvepria, pegfilgrastim, Date of authorisation: 18/11/2020, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 24 November 2025 - 15:40

Human medicines European public assessment report (EPAR): Nyvepria, pegfilgrastim, Date of authorisation: 18/11/2020, Revision: 8, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Nyvepria, pegfilgrastim, Date of authorisation: 18/11/2020, Revision: 8, Status: Authorised

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Sirturo, bedaquiline, Date of authorisation: 05/03/2014, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Cetrotide, cetrorelix, Date of authorisation: 12/04/1999, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): SonoVue, sulphur hexafluoride, Date of authorisation: 26/03/2001, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 60, Status: Authorised

Human medicines European public assessment report (EPAR): Nyvepria, pegfilgrastim, Date of authorisation: 18/11/2020, Revision: 8, Status: Authorised

Newsletters

Latest Newsletters

You are here

Newsletters

Latest Newsletters